Follow
Nicholas Arpaia
Nicholas Arpaia
Columbia University Irving Medical Center
Verified email at cumc.columbia.edu - Homepage
Title
Cited by
Cited by
Year
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
N Arpaia, C Campbell, X Fan, S Dikiy, J Van Der Veeken, P Deroos, H Liu, ...
Nature 504 (7480), 451-455, 2013
41362013
A distinct function of regulatory T cells in tissue protection
N Arpaia, JA Green, B Moltedo, A Arvey, S Hemmers, S Yuan, ...
Cell 162 (5), 1078-1089, 2015
8782015
Intestinal Blautia is associated with reduced death from graft-versus-host disease
RR Jenq, Y Taur, SM Devlin, DM Ponce, JD Goldberg, KF Ahr, ...
Biology of Blood and Marrow Transplantation 21 (8), 1373-1383, 2015
7382015
Programmable bacteria induce durable tumor regression and systemic antitumor immunity
S Chowdhury, S Castro, C Coker, TE Hinchliffe, N Arpaia, T Danino
Nature medicine 25 (7), 1057-1063, 2019
4062019
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
CR Gurbatri, I Lia, R Vincent, C Coker, S Castro, PM Treuting, ...
Science translational medicine 12 (530), eaax0876, 2020
3122020
TLR signaling is required for Salmonella typhimurium virulence
N Arpaia, J Godec, L Lau, KE Sivick, LM McLaughlin, MB Jones, ...
Cell 144 (5), 675-688, 2011
2902011
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations
S Affo, A Nair, F Brundu, A Ravichandra, S Bhattacharjee, M Matsuda, ...
Cancer cell 39 (6), 866-882. e11, 2021
2142021
Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts
S Bhattacharjee, F Hamberger, A Ravichandra, M Miller, A Nair, S Affo, ...
The Journal of clinical investigation 131 (11), 2021
1702021
Toll-like receptors: key players in antiviral immunity
N Arpaia, GM Barton
Current opinion in virology 1 (6), 447-454, 2011
1622011
Transmembrane mutations in Toll-like receptor 9 bypass the requirement for ectodomain proteolysis and induce fatal inflammation
ML Mouchess, N Arpaia, G Souza, R Barbalat, SE Ewald, L Lau, ...
Immunity 35 (5), 721-732, 2011
1252011
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
A Filliol, Y Saito, A Nair, DH Dapito, LX Yu, A Ravichandra, ...
Nature 610 (7931), 356-365, 2022
1182022
Microbial metabolites control gut inflammatory responses
N Arpaia, AY Rudensky
Proceedings of the National Academy of Sciences 111 (6), 2058-2059, 2014
1122014
A programmable encapsulation system improves delivery of therapeutic bacteria in mice
T Harimoto, J Hahn, YY Chen, J Im, J Zhang, N Hou, F Li, C Coker, K Gray, ...
Nature Biotechnology 40 (8), 1259-1269, 2022
1002022
Engineering bacteria as interactive cancer therapies
CR Gurbatri, N Arpaia, T Danino
Science 378 (6622), 858-864, 2022
872022
The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis
H Kobayashi, KA Gieniec, TRM Lannagan, T Wang, N Asai, Y Mizutani, ...
Gastroenterology 162 (3), 890-906, 2022
822022
deRoos P., Liu H., Cross JR, Pfeffer K., Coffer PJ, Rudensky AY Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
N Arpaia, C Campbell, X Fan, S Dikiy, J van der Veeken
Nature 504 (7480), 451-455, 2013
672013
A nonimmune function of T cells in promoting lung tumor progression
JA Green, N Arpaia, M Schizas, A Dobrin, AY Rudensky
Journal of Experimental Medicine 214 (12), 3565-3575, 2017
442017
Toll-like receptor-deficient mice reveal how innate immune signaling influences Salmonella virulence strategies
KE Sivick, N Arpaia, GL Reiner, BL Lee, BR Russell, GM Barton
Cell host & microbe 15 (2), 203-213, 2014
442014
Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity
TM Savage, RL Vincent, SS Rae, LH Huang, A Ahn, K Pu, F Li, ...
Science Advances 9 (10), eadc9436, 2023
282023
The impact of Toll-like receptors on bacterial virulence strategies
N Arpaia, GM Barton
Current opinion in microbiology 16 (1), 17-22, 2013
282013
The system can't perform the operation now. Try again later.
Articles 1–20